1. Home
  2. STRO vs GGR Comparison

STRO vs GGR Comparison

Compare STRO & GGR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • STRO
  • GGR
  • Stock Information
  • Founded
  • STRO 2003
  • GGR 2011
  • Country
  • STRO United States
  • GGR Taiwan
  • Employees
  • STRO N/A
  • GGR N/A
  • Industry
  • STRO Biotechnology: Biological Products (No Diagnostic Substances)
  • GGR Auto Manufacturing
  • Sector
  • STRO Health Care
  • GGR Consumer Discretionary
  • Exchange
  • STRO Nasdaq
  • GGR Nasdaq
  • Market Cap
  • STRO 94.9M
  • GGR 88.6M
  • IPO Year
  • STRO 2018
  • GGR N/A
  • Fundamental
  • Price
  • STRO $0.95
  • GGR $3.73
  • Analyst Decision
  • STRO Hold
  • GGR Hold
  • Analyst Count
  • STRO 7
  • GGR 2
  • Target Price
  • STRO $1.97
  • GGR $10.00
  • AVG Volume (30 Days)
  • STRO 1.6M
  • GGR 25.1K
  • Earning Date
  • STRO 11-10-2025
  • GGR 11-11-2025
  • Dividend Yield
  • STRO N/A
  • GGR N/A
  • EPS Growth
  • STRO N/A
  • GGR N/A
  • EPS
  • STRO N/A
  • GGR N/A
  • Revenue
  • STRO $104,473,000.00
  • GGR $289,420,000.00
  • Revenue This Year
  • STRO $65.48
  • GGR N/A
  • Revenue Next Year
  • STRO N/A
  • GGR $5.00
  • P/E Ratio
  • STRO N/A
  • GGR N/A
  • Revenue Growth
  • STRO N/A
  • GGR N/A
  • 52 Week Low
  • STRO $0.52
  • GGR $3.65
  • 52 Week High
  • STRO $4.60
  • GGR $13.99
  • Technical
  • Relative Strength Index (RSI)
  • STRO 45.59
  • GGR 56.04
  • Support Level
  • STRO $1.01
  • GGR $3.65
  • Resistance Level
  • STRO $1.20
  • GGR $4.15
  • Average True Range (ATR)
  • STRO 0.12
  • GGR 0.24
  • MACD
  • STRO -0.02
  • GGR -0.17
  • Stochastic Oscillator
  • STRO 8.09
  • GGR 11.04

About STRO Sutro Biopharma Inc.

Sutro Biopharma Inc is a clinical-stage drug discovery, development, and manufacturing company. It is mainly engaged in the development of biopharmaceutical products. The company manufactures next-generation protein therapeutics for cancer and autoimmune disorders through its proprietary integrated cell-free protein synthesis platform, XpressCF. Products offered by the company include STRO-001 for patients with multiple myeloma and non-Hodgkin lymphoma and STRO-002 for the treatment of ovarian and endometrial cancers. The company also pipeline contains STRO-004, STRO-006, STRO-00X, STRO-00Y, STRO-003, VAX24, VAX31, and Others.

About GGR Gogoro Inc.

Gogoro Inc is focused on eliminating the barriers to electric fuel adoption to bring swappable electric power within reach of every urban rider. Its battery swapping technology compromises an interoperable platform that seamlessly integrates a comprehensive ecosystem of hardware, software, and services, which consists of Gogoro Smart Batteries, GoStations, Gogoro Network Software & Battery Management Systems, Smartscooter, and related components and kits. Geographical presence in Taiwan and Other countries, majority of its revenue comes from Tiwan.

Share on Social Networks: